At the 41st Annual Tulane Eye Alumni Day at the Renaissance New Orleans Pere Marquette Hotel, Dr. Finger lectured about how and why his important innovations came to life. In the lecture, he discusses his early work on plaque microwave hyperthermia and TRT for intraocular tumors, pd-103 plaque radiation therapy, the slotted plaque, the amniotic [..] Read More…
New York Magazine recently compiled their annual list of “Best Doctors,” and our very own Dr. Paul Finger is a “Best Doctor” for the 12th time. Castle Connolly Medical Ltd., a New York City research and information company, creates this list yearly by using an online database of more than 53,000 Castle Connolly Top Doctors® [..] Read More…
In 2014, the First Eye Cancer Working Day was hosted by The Curie Institute in Paris, France. There, we decided to develop a Collaborative Open Access Surgical Textbook (COAST) aimed at offering guidance and international outreach for ophthalmologists in countries without eye cancer specialists. The resultant 5-year effort was spearheaded by Drs. Sonal Chaugule, Santosh [..] Read More…
The American Joint Committee on Cancer (AJCC) Cancer Staging Manual compiles all currently available knowledge on cancer staging at various anatomic sites. In 2016, they released the 8th edition, conjunctival melanoma staging system which features 12 new staging systems, a wide range of new staging definitions, and an emphasis on the personalized-medicine approach. This [..] Read More…
The Eye Cancer Foundation’s “2020 Campaign” claims another country, Ethiopia! We supported intensive training of a local ophthalmologist on advancements in retinoblastoma research, treatment, and diagnosis. Our most recent ECF grant recipient, Dr. Abu Amare, an ophthalmologist in Ethiopia, just completed a 6-month retinoblastoma fellowship at the Rasoole-E-Akram Hospital of The Iranian University of Medical [..] Read More…
The COMS Study What causes conjunctival melanoma (CoM)? Because of its rarity, much about CoM is unknown. Current medicine has yet to truly pinpoint any underlying genetic factors affecting CoM. In fact, no molecular drivers have been clearly defined in association with metastasis, recurrence prognosis, cell type, or other characteristic factors of CoM. In response [..] Read More…
In January of 2018, ECF fellow Dr. Sonal Chaugule, alongside Dr. Paul Finger and Dr. J. Park, published the study “Topical Chemotherapy for Giant Ocular Surface Squamous Neoplasia (OSSN) of the Conjunctiva and Cornea: Is Surgery Really Necessary?” in the Indian Journal of Ophthalmology (IJO). We are pleased to announce that this research has recently [..] Read More…
Day 5 at the ISOO: Corneal & Conjunctival Cancers Every two years, eye cancer specialists worldwide convene at the International Society of Ocular Oncology Conference in order to review latest research and encourage international collaboration within the field of ophthalmic oncology. For details on the ISOO Biennial Conference, read more here. The final day of the ISOO [..] Read More…
Day 4 at the ISOO: Retinoblastoma Every two years, eye cancer specialists worldwide convene at the International Society of Ocular Oncology Conference in order to review latest research and encourage international collaboration within the field of ophthalmic oncology. For details on the ISOO Biennial Conference, read more here. Preventing Retinoblastoma Dr. Helen Dimaras opened with her talk on [..] Read More…
Day 3 at the ISOO: Melanoma, Other Intraocular Cancers, and Basic Retinoblastoma Science Every two years, eye cancer specialists worldwide convene at the International Society of Ocular Oncology Conference in order to review latest research and encourage international collaboration within the field of ophthalmic oncology. For details on the ISOO Biennial Conference, read more here. Dr. Puneet [..] Read More…
"Very well treated by Dr. Finger. He explained everything I needed to know about my issue with detail and attention, putting me at ease and giving me confidence to handle this problem for the rest of my life.”
– N.N.
